These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18466898)

  • 1. GLP-1 agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid.
    Gault VA; Hölscher C
    Eur J Pharmacol; 2008 Jun; 587(1-3):112-7. PubMed ID: 18466898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Val8-glucagon-like peptide-1 protects against Aβ1-40-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats.
    Wang XH; Li L; Hölscher C; Pan YF; Chen XR; Qi JS
    Neuroscience; 2010 Nov; 170(4):1239-48. PubMed ID: 20727946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo.
    Jing W; Guo F; Cheng L; Zhang JF; Qi JS
    Neurosci Lett; 2009 Feb; 450(3):306-10. PubMed ID: 19059464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: a link between diabetes and Alzheimer's disease.
    McClean PL; Gault VA; Harriott P; Hölscher C
    Eur J Pharmacol; 2010 Mar; 630(1-3):158-62. PubMed ID: 20035739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease-resistant glucose-dependent insulinotropic polypeptide agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid.
    Gault VA; Hölscher C
    J Neurophysiol; 2008 Apr; 99(4):1590-5. PubMed ID: 18234983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid beta-protein fragment 31-35 suppresses long-term potentiation in hippocampal CA1 region of rats in vivo.
    Zhang JM; Wu MN; Qi JS; Qiao JT
    Synapse; 2006 Sep; 60(4):307-13. PubMed ID: 16786537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gly(14)]-humanin rescues long-term potentiation from amyloid beta protein-induced impairment in the rat hippocampal CA1 region in vivo.
    Guo F; Jing W; Ma CG; Wu MN; Zhang JF; Li XY; Qi JS
    Synapse; 2010 Jan; 64(1):83-91. PubMed ID: 19768812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonists of peroxisome proliferator-activated receptor-gamma attenuate the Abeta-mediated impairment of LTP in the hippocampus in vitro.
    Costello DA; O'Leary DM; Herron CE
    Neuropharmacology; 2005 Sep; 49(3):359-66. PubMed ID: 15993441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble beta-amyloid[25-35] reversibly impairs hippocampal synaptic plasticity and spatial learning.
    Holscher C; Gengler S; Gault VA; Harriott P; Mallot HA
    Eur J Pharmacol; 2007 Apr; 561(1-3):85-90. PubMed ID: 17320856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase C mediates amyloid beta-protein fragment 31-35-induced suppression of hippocampal late-phase long-term potentiation in vivo.
    Zhang JF; Qi JS; Qiao JT
    Neurobiol Learn Mem; 2009 Mar; 91(3):226-34. PubMed ID: 19061963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine enhances the depressive actions of A beta 1-40 on long-term potentiation in the rat hippocampal CA1 region in vivo.
    Freir DB; Herron CE
    J Neurophysiol; 2003 Jun; 89(6):2917-22. PubMed ID: 12611941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luteolin promotes long-term potentiation and improves cognitive functions in chronic cerebral hypoperfused rats.
    Xu B; Li XX; He GR; Hu JJ; Mu X; Tian S; Du GH
    Eur J Pharmacol; 2010 Feb; 627(1-3):99-105. PubMed ID: 19857483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A beta 25-35-induced depression of long-term potentiation in area CA1 in vivo and in vitro is attenuated by verapamil.
    Freir DB; Costello DA; Herron CE
    J Neurophysiol; 2003 Jun; 89(6):3061-9. PubMed ID: 12611943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. alpha7 Nicotinic acetylcholine receptor as a target to rescue deficit in hippocampal LTP induction in beta-amyloid infused rats.
    Chen L; Yamada K; Nabeshima T; Sokabe M
    Neuropharmacology; 2006 Feb; 50(2):254-68. PubMed ID: 16324726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble Arctic amyloid beta protein inhibits hippocampal long-term potentiation in vivo.
    Klyubin I; Walsh DM; Cullen WK; Fadeeva JV; Anwyl R; Selkoe DJ; Rowan MJ
    Eur J Neurosci; 2004 May; 19(10):2839-46. PubMed ID: 15147317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer amyloid beta-peptide A-beta25-35 blocks adenylate cyclase-mediated forms of hippocampal long-term potentiation.
    Bisel BE; Henkins KM; Parfitt KD
    Ann N Y Acad Sci; 2007 Feb; 1097():58-63. PubMed ID: 17413011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin rescues amyloid beta-induced impairment of hippocampal long-term potentiation.
    Lee CC; Kuo YM; Huang CC; Hsu KS
    Neurobiol Aging; 2009 Mar; 30(3):377-87. PubMed ID: 17692997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of IL-1 receptor antagonist on beta amyloid mediated depression of LTP in the rat CA1 in vivo.
    Schmid AW; Lynch MA; Herron CE
    Hippocampus; 2009 Jul; 19(7):670-6. PubMed ID: 19115392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
    Green BD; Lavery KS; Irwin N; O'harte FP; Harriott P; Greer B; Bailey CJ; Flatt PR
    J Pharmacol Exp Ther; 2006 Aug; 318(2):914-21. PubMed ID: 16648370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liraglutide protects against amyloid-β protein-induced impairment of spatial learning and memory in rats.
    Han WN; Hölscher C; Yuan L; Yang W; Wang XH; Wu MN; Qi JS
    Neurobiol Aging; 2013 Feb; 34(2):576-88. PubMed ID: 22592020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.